China to Allow Foreign Ownership, Operation of Hospitals

By Admin
China will allow foreign investors to wholly own and operate hospitals in seven cities and provinces as part of an effort to overhaul its health care sy...

China will allow foreign investors to wholly own and operate hospitals in seven cities and provinces as part of an effort to overhaul its health care system.

Further opening up the country’s fast-growing private hospital sector, the cities of Beijing, Tianjin and Shanghai and the provinces of Jiangsu, Fujian, Guangdong and Hainan will take part in the pilot test that was launched in July, according to an issued statement from the Ministry of Commerce and the National Health and Family Planning Commission.

Foreign investors in some parts of the country will be allowed to establish new hospitals or acquire existing ones.

According to McKinsey & Co., China’s healthcare spending is set to reach $1 trillion by 2020. Beijing has slowly allowed overseas money to enter the industry and has previously allowed foreign investors to own 70 percent stakes in hospital joint ventures.

Full ownership had been allowed in areas including Hong Kong, Macau and Taiwan, according to Reuters.

A Deutsche Bank report noted that there were 11,300 private hospitals in China last year, a massive increase from the 3,200 that were listed in 2005. The report also stated that 8,000 public hospitals were likely to be privatized within the following 5-10 years.

Approvals for foreign-owned hospitals will be overseen by provincial governments, the Ministry of Commerce said, adding that only investors from Macau, Taiwan and Hong Kong can only practice traditional Chinese medicine.

Chinese hospitals lack funding and suffer from a steep gap between urban and rural care, often leading to high rates of bribery and tension between patients and doctors.

The pilot program is an attempt to reform the world’s second-largest economy to give private and foreign investors greater access to enhance efficiency, technological awareness and coverage for health care. 

Share

Featured Articles

Comarch Diagnostic Point Boost for European Health Insurance

Healthtech specialist Comarch introduces Diagnostic Point, designed to improve health insurance across European markets

McKinsey: Women More Likely to die of Heart Attack Than Men

McKinsey Health Institute's Lucy Pérez says cardiovascular disease top killer of women yet physicians don't know their heart attack symptoms are different

Novo Nordisk Buys $1bn Cardior in CardioVascular Move

As Novo Nordisk expands into heart medicines, we profile the Danish pharma giant who in 1923 was the first to make insulin commercially available

Shoddy Chinese Syringes Sees BD Ramp-up Production

Procurement & Supply Chain

AI Tool 'Picks up Early-stage Breast Cancers Doctors Missed'

Technology & AI

AstraZeneca Buys $2bn Fusion in Next-gen Cancer Drugs Move

Medical Devices & Pharma